WINDSOR HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: B86057 | LEEDS, LS27 9NB
Showing results 351-400 of 751
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 85 | 4,640 | £720 | +72.0% ▲ | |
| 84 | 2,225 | £3.9K | +123.4% ▲ | |
| 84 | 2,050 | £1.1K | +8.6% ▲ | |
| Alogliptin | 83 | 2,772 | £2.5K | -67.3% ▼ |
| Bicalutamide | 83 | 1,270 | £95 | +156.6% ▲ |
| Dorzolamide | 83 | 6,090 | £2.4K | -0.1% vs avg |
| 81 | 10.1K | £446 | -38.2% ▼ | |
| Rasagiline mesilate | 80 | 1,134 | £742 | +115.4% ▲ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 80 | 1,997 | £112 | +99.1% ▲ |
| 80 | 684 | £1.3K | +230.2% ▲ | |
| Glucose | 79 | 10.8K | £972 | +51.9% ▲ |
| Fluorouracil (Sunscreen) | 79 | 3,170 | £2.5K | +116.9% ▲ |
| 79 | 4,636 | £890 | -1.8% vs avg | |
| Sodium picosulfate | 77 | 24.6K | £2.2K | +112.1% ▲ |
| Prasugrel | 77 | 1,134 | £228 | +145.0% ▲ |
| Biphasic insulin lispro | 77 | 745 | £4.6K | +79.3% ▲ |
| Dabigatran etexilate | 76 | 2,648 | £2.1K | +46.8% ▲ |
| Dexamfetamine sulfate | 76 | 3,753 | £3.7K | +111.4% ▲ |
| Safinamide | 76 | 1,147 | £2.5K | +277.3% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 75 | 9,284 | £651 | -58.3% ▼ |
| Norethisterone | 75 | 3,169 | £534 | +54.6% ▲ |
| 75 | 1,010 | £2.8K | +56.8% ▲ | |
| Phosphates (Rectal) | 74 | 182 | £6.6K | +505.4% ▲ |
| Linaclotide | 74 | 2,352 | £3.0K | +305.1% ▲ |
| Ciprofloxacin | 74 | 1,887 | £218 | +85.6% ▲ |
| Mefenamic acid | 74 | 3,131 | £583 | +63.8% ▲ |
| Metronidazole | 74 | 3,090 | £1.0K | +96.9% ▲ |
| Dutasteride | 73 | 1,176 | £75 | +42.2% ▲ |
| Cenobamate | 72 | 2,968 | £18.1K | +197.2% ▲ |
| Tablets/capsules micronutrient supplement (0913282) | 70 | 3,074 | £2.2K | +568.4% ▲ |
| Brinzolamide and timolol | 69 | 475 | £808 | +82.6% ▲ |
| 69 | 2,206 | £1.3K | -32.5% ▼ | |
| 69 | 232 | £1.1K | +122.5% ▲ | |
| Terbinafine hydrochloride | 67 | 1,980 | £356 | +80.6% ▲ |
| Enoxaparin | 66 | 2,209 | £11.6K | +222.0% ▲ |
| Meloxicam | 65 | 1,915 | £56 | -1.7% vs avg |
| 65 | 390 | £2.2K | +81.8% ▲ | |
| 65 | 1,670 | £498 | +50.8% ▲ | |
| Rabeprazole sodium | 64 | 3,612 | £337 | +24.1% ▲ |
| Exemestane | 64 | 2,708 | £500 | +97.0% ▲ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 64 | 318.8K | £4.3K | -48.3% ▼ |
| 64 | 3,250 | £14.6K | +186.8% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 63 | 2,296 | £315 | +81.1% ▲ |
| Etonogestrel | 63 | 63 | £5.3K | +118.0% ▲ |
| Zuclopenthixol hydrochloride | 61 | 7,400 | £221 | +93.4% ▲ |
| Oral rehydration salts | 60 | 3,484 | £1.5K | +107.7% ▲ |
| Labetalol hydrochloride | 58 | 4,186 | £449 | +155.4% ▲ |
| Oseltamivir phosphate | 58 | 530 | £514 | +433.4% ▲ |
| Combined ethinylestradiol 20mcg | 58 | 6,220 | £1.8K | +11.0% ▲ |
| Emollient bath and shower preparations | 58 | 33.1K | £410 | -7.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.